Erratum: Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial (Hepatology (2009) 50 (1818-1826) DOI: 10.1002/hep.23239));Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

Hepatology

Volumn 50, Issue 6, 2009, Pages 1818-1826

  Abdelmalek, Manal F ^a,c   Sanderson, Schuyler O ^b,g   Angulo, Paul ^b,g   Soldevila Pico, Consuelo ^a,d   Liu, Chen ^b,d   Peter, Joy ^a,d   Keach, Jill ^a,f   Cave, Matt ^a,e,f   Chen, Theresa ^b,f   McClain, Craig J ^a,b,e,f   Lindor, Keith D ^a,g  

^a Division of Gastroenterology   (United States)

^b Department of Pathology ^*  (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BETAINE; CYTOKINE; GLUCOSE; INSULIN; PLACEBO; S ADENOSYLHOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOATING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONALCOHOLIC FATTY LIVER; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VOMITING;

EID: 73149092115     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23642     Document Type: Erratum

References (25)

1. Angulo P. Treatment of nonalcoholic fatty liver disease. Ann Hepatol 2002;1:12-19.
2. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123: 134-140.
3. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001;7:608-614.
4. Barak AJ, Tuma DJ. Betaine, metabolic by-product or vital methylating agent? Life Sci 1983;32:771-774.
5. [No authors listed.] Alleviation of dietary cirrhosis by betaine and other lipotropic agents. Nutr Rev 1969;27:269-271.
6. Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001;96:2711-2717.
7. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474. 8. Sakura N, Ono H, Nomura S, Ueda H, Fujita N. Betaine dose and treatment intervals in therapy for homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 1998;21:84-85.
8. Food and Drug Administration. Cystadane Product Information. www.fda.gov/medwatch/SAFETY/2006/Feb-PI/Cystadane-PI.pdf 2006.
9. Anonymous. Plan and Operation of the Third National Health and Nutrition Examination Survey. Washington, DC: National Center for Health Statistics; 1994.
10. Capdevila A, Burk RF, Freedman J, Frantzen F, Alfheim I, Wagner C. A simple rapid immunoassay for S-adenosylhomocysteine in plasma. J Nutr Biochem 2007;18:827-831.
11. Wang W, Kramer PM, Yang S, Pereira MA, Tao L. Reversed-phase highperformance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J Chromatogr B Biomed Sci Appl 2001;762:59-65.
12. De Antonis KM, Brown PR, Cohen SA. High-performance liquid chromatographic analysis of synthetic peptides using derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Anal Biochem 1994;223:191-197.
13. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. HEPATOLOGY 2004;40:1387-1395.
14. Ipekci SH, Basaranoglu M, Sonsuz A. The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2003;36:371.
15. Halsted CH, Villanueva JA, Devlin AM. Folate deficiency, methionine metabolism, and alcoholic liver disease. Alcohol 2002;27:169-172.
16. Barak AJ, Beckenhauer HC, Junnila M, Tuma DJ. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin Exp Res 1993;17: 552-555.
17. Zhu X, Song J, Mar MH, Edwards LJ, Zeisel SH. Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem J 2003;370: 987-993.
18. Kharbanda KK, Mailliard ME, Baldwin CR, Beckenhauer HC, Sorrell MF, Tuma DJ. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol 2007;46:314-321.
19. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003;124:1488-1499.
20. Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ. Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J Nutr 2003;133:2845-2848.
21. Garcia-Ruiz C, Morales A, Colell A, Ballesta A, Rodes J, Kaplowitz N, et al. Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. HEPATOLOGY 1995;21:207-214.
22. Colell A, Garcia-Ruiz C, Miranda M, Ardite E, Mari M, Morales A, et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998;115:1541-1551.
23. Miglio F, Rovati LC, Santoro A, Setnikar I. Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study. Arzneimittelforschung 2000;50:722-727.
24. Mukherjee S, Tamara B, Schafer D, Barak A, Sorrell M, Tuma D. Impact of betaine on hepatic fibrosis and homocysteine in nonalcoholic steatohepatitis-a prospective cohort study. HEPATOLOGY 2005;42(suppl 1): 610A.
25. Song Z, Deaciuc I, Zhou Z, Song M, Chen T, Hill D, et al. Involvement of AMP-activated protein kinase in beneficial effects of betaine on highsucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 2007;293:G894-902.